Myasthenia Gravis - Argenx ARGX-999-2-MG-2000

Myasthenia Gravis – Argenx ARGX-999-2-MG-2000

Profound Research is enrolling a Myasthenia Gravis (MG) study that is assessing an investigational medication to see if it improves MG symptoms.

To be eligible to participate, you must:

Additional criteria apply.

Qualified participants will receive:

See if you qualify today.

Trial Interest Form

I am a...

First Name(Required)

Last Name(Required)

Location(Required)

Phone(Required)

Email(Required)

Gender

Conditions

Race

Contact Preference

How did you hear about us?

Other (Please specify)

This field is hidden when viewing the form

Trial (Origination Page)

This field is hidden when viewing the form

UTM Source

This field is hidden when viewing the form

UTM Medium

This field is hidden when viewing the form

UTM Campaign

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

Phone(Required)

Zip Code(Required)

What is the best way to contact you?(Required)

Comments(Required)

Please let us know what's on your mind. Have a question for us? Ask away.

This field is hidden when viewing the form

Origination Page

Myasthenia Gravis – Argenx ARGX-999-2-MG-2000